Circulating tumor DNA as a marker of minimal residual disease following local treatment of metastases from colorectal cancer.

CONCLUSION: The presence of ctDNA following local treatment of metastatic CRC is associated with an increased risk of recurrence and a short time to failure. PMID: 32790489 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32790489?dopt=Abstract

Source: Acta Oncologica - August 12, 2020 Category: Cancer & Oncology Authors: Boysen AK, Pallisgaard N, Andersen CSA, Spindler KG Tags: Acta Oncol Source Type: research